Literature DB >> 8564256

Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

M Perretti1, C Szabó, C Thiemermann.   

Abstract

1. The effect of systemic treatment of mice with murine recombinant interleukin-4 (IL-4) or interleukin-10 (IL-10) on neutrophil infiltration into a specific tissue site and nitric oxide (NO) production from peritoneal macrophages was investigated. 2. Intravenously (i.v.) administered IL-4 (0.01-10 micrograms per mouse, approximately 0.3-300 micrograms kg-1, i.v.) and IL-10 (0.01-1 micrograms per mouse, approximately 0.3-30 micrograms kg-1, i.v.) dose-dependently inhibited neutrophil accumulation into a 6-day-old murine air-pouch induced by local application of interleukin-1 beta (IL-1 beta, 5 ng), with approximate ED50s of 0.35 and 0.90 micrograms, respectively. Neither IL-4 (1 micrograms, 30 micrograms kg-1, i.v.) nor IL-10 (1 micrograms, 30 micrograms kg-1, i.v.) prevented leucocyte accumulation in the mouse air-pouches when interleukin-8 (IL-8, 1 micrograms) was used as chemoattractant. Similarly, neither cytokine had any effect on the in vitro up-regulation of CD11b antigen on the surface of murine circulating neutrophils. 3. Treatment of mice with lipopolysaccharide (LPS, 0.3 mg kg-1, i.p.) caused an increase in the formation of NO (measured as nitrite accumulation) in the supernatant of peritoneal macrophages ex vivo. Pretreatment of mice with IL-4 (0.01-1 micrograms i.v., 20 min before LPS), but not with IL-10 (1 micrograms i.v., 20 min before LPS), caused a dose-dependent reduction in this LPS-stimulated formation of nitrite by peritoneal macrophages ex vivo. 4. Activation of murine macrophages with LPS (1 microgram ml-1 for 24 h) in vitro caused a significant increase in nitrite release in the supernatant of these cells. Pretreatment of either J774.2 or peritoneal macrophages with IL-4 (0.1-1 microg ml-1, 20 min before LPS), but not with IL-1O (1 microg ml', 20 min before LPS) caused a concentration-related attenuation of this LPS-stimulated nitrite formation.5 Thus, both IL-4 and IL-10 inhibit the migration of leucocytes (stimulated by IL-1beta>) in vivo; IL-4 (but not IL-10) inhibits the induction of NO synthase caused by LPS in murine macrophages in vitro and ex vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564256      PMCID: PMC1908976          DOI: 10.1111/j.1476-5381.1995.tb15061.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  The effects of interleukin-8 on neutrophil fMetLeuPhe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines.

Authors:  P J Roberts; A R Pizzey; A Khwaja; J E Carver; A R Mire-Sluis; D C Linch
Journal:  Br J Haematol       Date:  1993-08       Impact factor: 6.998

2.  Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells.

Authors:  P Kubes; S Kanwar; X F Niu; J P Gaboury
Journal:  FASEB J       Date:  1993-10       Impact factor: 5.191

3.  Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody.

Authors:  M Perretti; A Ahluwalia; J G Harris; N J Goulding; R J Flower
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

4.  Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors.

Authors:  M Perretti; A Ahluwalia; R J Flower; S Manzini
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling.

Authors:  K Ley; J B Baker; M I Cybulsky; M A Gimbrone; F W Luscinskas
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

6.  Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.

Authors:  C Szabó; C C Wu; J A Mitchell; S S Gross; C Thiemermann; J R Vane
Journal:  Circ Res       Date:  1993-12       Impact factor: 17.367

7.  Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts.

Authors:  R P Donnelly; L J Crofford; S L Freeman; J Buras; E Remmers; R L Wilder; M J Fenton
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

8.  Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin.

Authors:  A Harada; N Sekido; K Kuno; M Akiyama; T Kasahara; I Nakanishi; N Mukaida; K Matsushima
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

9.  Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4.

Authors:  W A Wertheim; S L Kunkel; T J Standiford; M D Burdick; F S Becker; C A Wilke; A R Gilbert; R M Strieter
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

10.  Protective effects of IL-4 and IL-10 against immune complex-induced lung injury.

Authors:  M S Mulligan; M L Jones; A A Vaporciyan; M C Howard; P A Ward
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

View more
  14 in total

1.  Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Authors:  Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

2.  Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation.

Authors:  M N Ajuebor; L Virág; R J Flower; M Perretti; C Szabó
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

3.  Interleukin (IL)-4 induces production of cytokine-induced neutrophil chemoattractants (CINCs) and intercellular adhesion molecule (ICAM)-1 in lungs of asthmatic rats.

Authors:  Ya-Li Guo; Hong Huang; Da-Xiong Zeng; Jian-Ping Zhao; Hui-Juan Fang; Jean-Pierre Lavoie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

4.  Cytokine modulation of liver annexin 1 expression during experimental endotoxemia.

Authors:  C de Coupade; M N Ajuebor; F Russo-Marie; M Perretti; E Solito
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.

Authors:  Mira Jung; Yonggang Ma; Rugmani Padmanabhan Iyer; Kristine Y DeLeon-Pennell; Andriy Yabluchanskiy; Michael R Garrett; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2017-04-24       Impact factor: 17.165

7.  Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Authors:  Krisztián Németh; Asada Leelahavanichkul; Peter S T Yuen; Balázs Mayer; Alissa Parmelee; Kent Doi; Pamela G Robey; Kantima Leelahavanichkul; Beverly H Koller; Jared M Brown; Xuzhen Hu; Ivett Jelinek; Robert A Star; Eva Mezey
Journal:  Nat Med       Date:  2008-11-21       Impact factor: 53.440

8.  IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.

Authors:  F Jacobs; D Chaussabel; C Truyens; V Leclerq; Y Carlier; M Goldman; B Vray
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

9.  Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice.

Authors:  A Räisänen-Sokolowski; T Glysing-Jensen; M E Russell
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen.

Authors:  A S MacFarlane; M G Schwacha; T K Eisenstein
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.